Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. 2004

P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
Servicio de Alergia, Hospital de Basurto, Bilbao, Spain.

BACKGROUND New in vitro diagnostic methods for IgE-mediated drug allergic reactions, such as basophil activation test and antigen specific sulfidoleukotriene test, have proven their usefulness in patients with positive skin tests. OBJECTIVE To assess the usefulness of basophil activation test and antigen specific sulfidoleukotriene test in the diagnosis of patients with IgE-mediated allergy to Betalactam antibiotics and negative skin tests. METHODS The 23 patients included in the study underwent basophil activation test, antigen specific sulfidoleukotriene test and specific IgE. The patients were classified into three groups. patients with positive specific IgE. patients with a unique immediate reaction to Betalactams, negative specific IgE and positive oral provocation tests. And Group C: patients with at least two immediate reactions induced by Betalactams and negative specific IgE. RESULTS The sensitivity/specificity of the different tests are: basophil activation test 39.1 %/93.3%, antigen specific sulfidoleukotriene test 22.7%/83.3%, specific IgE 21.7%/86.7%. The joint use of the three tests allows diagnosis of 60.9% of the patients. CONCLUSIONS In vitro diagnostic tests, especially basophil activation test, are very important tools in the diagnosis of patients with IgE-mediated allergy to Betalactams and negative skin tests, avoiding performance of potentially dangerous oral provocation tests in a high percentage of cases.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
January 2009, Journal of investigational allergology & clinical immunology,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
January 2021, Einstein (Sao Paulo, Brazil),
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
April 2008, Revue medicale suisse,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
January 2007, Allergy,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
November 2009, Allergy,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
December 2018, Cutaneous and ocular toxicology,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
August 2007, Current opinion in allergy and clinical immunology,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
August 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
January 2009, Acta clinica Belgica,
P M Gamboa, and M C García-Avilés, and I Urrutia, and I Antépara, and R Esparza, and M L Sanz
June 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
Copied contents to your clipboard!